Shares of Cybin Inc. (OTCMKTS:CLXPF – Get Free Report) hit a new 52-week high during trading on Tuesday . The company traded as high as $9.95 and last traded at $9.47, with a volume of 182862 shares traded. The stock had previously closed at $9.91.
Cybin Price Performance
The stock’s 50-day moving average price is $10.45 and its 200 day moving average price is $4.74. The firm has a market capitalization of $1.41 billion and a PE ratio of -39.42.
Cybin Company Profile
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
Read More
- Five stocks we like better than Cybin
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Micron Stock Under $100: Seize the AI-Driven Upside
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- NYSE Stocks Give Investors a Variety of Quality Options
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
